Zoledronic acid inhibits TSC2-null cell tumor growth via RhoA/YAP signaling pathway in mouse models of lymphangioleiomyomatosis.
Dandan ZhaoJing WuYinjuan ZhaoWei ShaoQi ChengXiaoyan ShaoXianwen YuanJuan YeJianpu GaoMeiling JinChaojun LiXiaolin ChenYue ZhaoDandan ZhaoPublished in: Cancer cell international (2020)
ZA promotes cell apoptosis in TSC2-null cells through the RhoA/YAP signaling pathway. ZA may be used for the clinical treatment of LAM.